Sulbactam
Sponsors
Friedrich-Schiller-Universitaet Jena, Sutep Jaruratanasirikul, Entasis Therapeutics
Conditions
Acinetobacter Baumannii InfectionAcinetobacter Baumannii-calcoaceticus ComplexAcinetobacter InfectionsBacteremiaColistin Resistant ABCHospital-acquired Bacterial PneumoniaInfectious endocarditis caused by Gram-positive cocci (staphylococciVentilator-associated Bacterial Pneumonia
Phase 1
Phase 3
Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex
CompletedNCT03894046
Start: 2019-09-05End: 2021-07-26Updated: 2023-02-01
Efficacy and safety of Dalbavancin in the treatment of infective Endocarditis caused by gram-positive cocci
Not yet recruitingCTIS2026-526149-91-00
Target: 166Updated: 2026-06-30